Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties

Advanced prostate adenocarcinomas enriched in stem-cell features, as well as variant androgen receptor (AR)-negative neuroendocrine (NE)/small-cell prostate cancers are difficult to treat, and account for up to 30% of prostate cancer-related deaths every year. While existing therapies for prostate c...

Descripción completa

Detalles Bibliográficos
Autores principales: Paranjape, A N, Soundararajan, R, Werden, S J, Joseph, R, Taube, J H, Liu, H, Rodriguez-Canales, J, Sphyris, N, Wistuba, I, Miura, N, Dhillon, J, Mahajan, N, Mahajan, K, Chang, J T, Ittmann, M, Maity, S N, Logothetis, C, Tang, D G, Mani, S A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116559/
https://www.ncbi.nlm.nih.gov/pubmed/26804168
http://dx.doi.org/10.1038/onc.2015.498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116559/
https://www.ncbi.nlm.nih.gov/pubmed/26804168
http://dx.doi.org/10.1038/onc.2015.498

Ejemplares similares